<a target=_blank class=ftalternatingbarlinklarge href="http://www.ec.gc.ca/ozone/DOCS/SandS/mdi/EN/profession/presentationPP.cfm
">http://www.ec.gc.ca/ozone/DOCS...on/presentationPP.cfm
</a>
Phasing Out CFC Inhalers
Protecting Human Health and the Ozone Layer
Inhalers in Canada
2.7 million Canadians have asthma or COPD
79% of all inhaled medicines delivered by CFC MDIs
55% salbutamol formulations
22% beclomethasone formulation
23% other formulations
13% dry powder inhalers
8% nebulizer formulations
-drug-by-drug basis
-sufficient quantities of alternatives must be available
-<b>target complete phase-out by 2005 <b>
-education is essential
">http://www.ec.gc.ca/ozone/DOCS...on/presentationPP.cfm
</a>
Phasing Out CFC Inhalers
Protecting Human Health and the Ozone Layer
Inhalers in Canada
2.7 million Canadians have asthma or COPD
79% of all inhaled medicines delivered by CFC MDIs
55% salbutamol formulations
22% beclomethasone formulation
23% other formulations
13% dry powder inhalers
8% nebulizer formulations
-drug-by-drug basis
-sufficient quantities of alternatives must be available
-<b>target complete phase-out by 2005 <b>
-education is essential